The expression of RRM1 T52A showed slight effects on tumor growth (Fig. 6f and Supplementary Fig. 9a, b), which is consistent with the observations that the T52A mutation had limited effects on RNR activity in the absence of AMPK activation (Fig. 5a). The gene discussed is PRKAA2; the disease is neoplasm.